USE OF PLATELET-RICH PLASMA AND PLATELET-RICH FIBRIN IN THE HEALING OF CHRONIC WOUNDS

• Autor(a) principal: Nascimento, Wanderlene de Oliveira do
• Data de Publicação: 2024
• Outros Autores: Lima, Elaynne Jeyssa Alves, Ferreira, Maria Teresa da Silva, Alves, Anne Karolinne e Silva, Carvalho, Marle Araújo Luz de, Lages, Maria Gizelda Gomes, Soares, Ana Hilda Silva, Pirozzi, Donato, Sousa, Mirella Lino de, Sousa , Mirna Freitas de, Marins, Renan Augusto, Lessa, Mikhael Buzon, Silva, Antonio Inácio da, Lima, Adeânio Almeida, Schiavon, Isabel Cristina Adão, Cucinelli, Andrezza do Espírito Santo
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Brazilian Journal of Implantology and Health Sciences
• Texto Completo: https://bjihs.emnuvens.com.br/bjihs/article/view/1034
• topic: Plasma rico em plaquetas; Fibrina rica em plaquetas; Doenças Crônicas; Cicatrização; Platelet-rich plasma; Platelet-rich fibrina; Chronic diseases; Healing; Plasma rico en plaquetas; Fibrina rica en plaquetas; Enfermedades crónicas; Curación

Objective: To analyze and evaluate the efficacy and benefits of using platelet-rich plasma and platelet-rich fibrin as therapies to promote the healing of chronic wounds. Methodology: This is a literature review in which the construction of the research is based on the question "What are the efficacy and benefits of using platelet-rich plasma and platelet-rich fibrin to promote the healing of chronic wounds?" The research was conducted in 2023 by consulting the MEDLINE and LILACS databases. Results: Platelet-rich plasma and platelet-rich fibrin have shown efficacy in promoting the healing of chronic wounds. Platelet-rich plasma, with its increased concentration of platelets and growth factors, has shown significant results in closing diabetic and venous ulcers, reducing healing time and decreasing wound dimensions. Similarly, platelet-rich fibrin, a complex fibrin matrix, proved crucial in the healing of diabetic wounds, providing a continuous release of growth factors and improving treatment efficacy. Conclusion: Both therapies have remarkable benefits, offering an optimistic outlook for the effective management of persistent wounds and improving the quality of life of patients with chronic wounds.